Загрузка...
Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: the PRISE-MD trial
Management of Major Depressive Disorder (MDD) might be improved by a biomarker to predict whether a selected medication is likely to lead to remission. We previously reported on a quantitative electroencephalogram-based biomarker, the Antidepressant Treatment Response (ATR) index, that integrated re...
Сохранить в:
| Опубликовано в: : | J Psychiatr Res |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141143/ https://ncbi.nlm.nih.gov/pubmed/32169689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2020.02.028 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|